SCHEMBL7436263

SCHEMBL7436263

O=C(O)C1=C(c2cccs2)Nc2n[nH]cc2C1c1ccccc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
MEN1 O00255 4/20 0.34
KMT2A Q03164 4/20 0.34
FTO Q9C0B1 1/20 0.34
KDM4E B2RXH2 7/20 0.33
GAA P10253 4/20 0.33
ALDH1A1 P00352 4/20 0.33
HPGD P15428 4/20 0.33
GLA P06280 2/20 0.33
CASP1 P29466 2/20 0.33
CASP7 P55210 2/20 0.33
HSD17B10 Q99714 2/20 0.33
HTT P42858 1/20 0.33
SLC16A3 O15427 1/20 0.32
SLC16A1 P53985 1/20 0.32
MCTS1 Q9ULC4 1/20 0.32
PYGL P06737 4/20 0.32
PYGM P11217 4/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6292459 0.86 TSHR (0.43) LMNAMAPTNPSR1MEN1KMT2A
SCHEMBL6292506 0.82 MAPT (0.39) LMNAMAPTNPSR1MEN1KMT2A
SCHEMBL7017903 0.78 ALDH1A1 (0.41) LMNAMAPTKDM4EGAAALDH1A1
SCHEMBL7436392 0.76 PYGL (0.39) KDM4EGAAALDH1A1HPGDGLA
SCHEMBL7441431 0.74 PYGL (0.39) LMNAMAPTNPSR1KMT2AKDM4E
SCHEMBL7025273 0.74 TBXA2R (0.41) LMNAMAPTNPSR1MEN1KMT2A
SCHEMBL7017155 0.74 KDM4E (0.39) KDM4EGAAALDH1A1HPGDGLA
SCHEMBL6293743 0.74 USP7 (0.36) LMNAMAPTNPSR1MEN1KMT2A
SCHEMBL6293440 0.72 ADORA3 (0.47) LMNAMAPTNPSR1MEN1KMT2A
SCHEMBL6293653 0.70 KDM4E (0.51) LMNAMAPTNPSR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002062795-A9 DIHYDROPYRAZOLOPYRIDINE COMPOUNDS AND PHARMACEUTICAL USE THEREOF MITSUBISHI PHARMA CORP (JP) 2002-10-10 WO disclosed